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Peptides comprising residues 106–126 of the human
prion protein (PrP) exhibit many features of the full-
length protein. PrP(106–126) induces apoptosis in
neurons, forms fibrillar aggregates, and can mediate
the conversion of native cellular PrP (PrPC) to the
scrapie form (PrPSc). Despite a wide range of
biochemical and biophysical studies on this peptide,
including investigation of its propensity for aggrega-
tion, interactions with cell membranes, and PrP-like
toxicity, the structure of amyloid fibrils formed by
PrP(106–126) remains poorly defined. In this study
we use solid-state nuclear magnetic resonance to
define the secondary and quaternary structure of
PrP(106–126) fibrils. Our results reveal that PrP(106–
126) forms in-register parallel b sheets, stacked in
an antiparallel fashion within the mature fibril. The
close intermolecular contacts observed in the fibril
core provide a rational for the sequence-dependent
behavior of PrP(106–126), and provide a basis for
further investigation of its biological properties.
INTRODUCTION
Prion diseases are fatal neurodegenerative disorders character-
ized by the accumulation of a misfolded and infectious form of
the prion protein (PrP) (Prusiner, 1982; Prusiner et al., 1998).
These diseases include bovine spongiform encephalopathy in
cattle, and Creutzfeldt-Jakob disease (CJD) in humans. The
pathogenic form of PrP (PrPSc) is generally considered to be
the causative agent for prion disease, due to the ability of PrPSc
to propagate the misfolding of PrPC in exposed cells, leading to
conversion to the disease phenotype in the host organism
(Prusiner, 1996; Riesner, 2003; Weissmann, 2004). The mecha-
nism through which PrPSc catalyzes PrPC conversion from
a soluble, helical protein into b sheet containing aggregates
has not yet been elucidated, nor has the structure of PrPSc.
Therefore, structural studies of PrP and related peptides in
nonnative conformations represent an important step toward
understanding the molecular details of prion disease.
PrP(106–126) is a 21-amino acid peptide derived from the
unstructured N terminus of PrP, and exhibits many characteris-
tics of the full-length protein (Singh et al., 2002). For instance,
PrP(106–126) has been shown to form amyloid fibrils and toStructure 17, 4cause apoptosis of cultured neurons through mechanisms that
appear similar to those induced by exposure to PrPSc (Ettaiche
et al., 2000; Forloni et al., 1993, 2000; Thellung et al., 2000). Of
particular interest is the observation that toxicity of PrP(106–
126) requires the presence of full-length PrPC in the target cells,
consistent with its reported ability to mediate the conversion of
PrPC to PrPSc, in vitro and in vivo, and implying a direct interac-
tion between the peptide and PrPC (Forloni et al., 1993; Jobling
et al., 1999; Salmona et al., 1999; Selvaggini et al., 1993).
Although the molecular structure of residues 106–126 in PrPSc
remains unknown, it has been shown that monoclonal antibodies
raised against aggregated forms of PrP(106–126) also recognize
PrPSc in human brain tissue from CJD patients, strongly suggest-
ing a similarity between the structures adopted by aggregates of
the PrP(106–126) peptide and residues 106–126 in full-length
PrPSc (Jones et al., 2008).
PrP(106–126) also shares common features of the fibril form-
ing proteins observed in amyloid diseases. In particular, there
is evidence for direct formation of cation channels as well as
non-specific disruption of model membranes by oligomeric
PrP(106–126) (Dupiereux et al., 2005; Kourie and Culverson,
2000; Lin et al., 1997), similar to the effects of other amyloid
proteins (Demuro et al., 2005; Kayed et al., 2003; Quist et al.,
2005). Thus, studies of PrP(106–126) structure are likely to
shed light on common elements of amyloid disease. Models
for amyloid fibrils of this peptide have been proposed based
on site-directed mutagenesis studies (Salmona et al., 1999),
and on amide hydrogen exchange data (Kuwata et al., 2003).
In addition, recent Fourier transform infrared spectroscopy
(FTIR) and solid-state nuclear magnetic resonance (NMR) inves-
tigations have revealed an antiparallel b sheet arrangement in
fibrils of an amidated form of the related peptide PrP(109–122)
(Lee et al., 2008; Silva et al., 2003). However, despite extensive
biochemical characterization, no high-resolution structural
studies of aggregated states of PrP(106–126) have been
reported.
Here we present a detailed structural model for amyloid fibrils
formed by PrP(106–126) based on solid-state NMR, transmis-
sion electron microscopy (TEM), and atomic force microscopy
(AFM). In particular, we have identified intermolecular contacts
between peptides that are characteristic of parallel b sheets,
as well as contacts arising from an antiparallel packing of sheets
within the fibril. These measurements allow unambiguous defini-
tion of the key interactions which define the structure of the fibril
core. In the resulting structural model, the hydrophobic residues
pack in a manner similar to the recently described class 1 steric
zipper motif (Sawaya et al., 2007). This core structure is further17–426, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 417
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Structure of huPrP(106–126) Fibrilsstabilized by intersheet salt bridges between the C terminus and
the side chain of Lys110. This model provides a basis for under-
standing the effects of sequence alterations and modifications
on the biological and biophysical behavior of this peptide.
RESULTS
PrP(106–126) Forms Amyloid Fibrils
with Characteristics of a Cross-b Structure
Fibrillar aggregates formed by PrP(106–126) were visualized by
TEM and AFM, with representative images shown in Figure 1.
Negative stain TEM images (Figure 1A) revealed straight,
untwisted, unbranched fibrils 0.5–1 mm long and 5–7 nm wide.
The morphology of PrP(106–126) fibrils was uniform throughout
all samples imaged, and is consistent with previous reports of
amyloid fibrils formed by this peptide (Forloni etal., 1993; Salmona
et al., 1999; Selvaggini et al., 1993). AFM measurements
(Figure 1B) revealed a height of 2.4± 0.4 nmforall fibrilsmeasured.
In comparison with the 4–5 nm heights measured for fibrils formed
by amylin and b-amyloid (Luca et al., 2007; Petkova et al., 2002),
each of which contains a core of four stacked b sheets, we expect
PrP(106–126) fibrils to be composed of two sheets.
Circular dichroism (CD) spectra obtained on suspensions of
PrP(106–126) fibrils are shown in Figure 1C, and exhibit a minimum
at 216 nm, characteristic of b sheet secondary structure. This is in
contrast to spectra of PrP(106–126) in 1,1,1,3,3,3-hexafluoroiso-
propanol (HFIP), which indicate that the peptide is unstructured
before fibril formation. Thioflavin-T (ThT) binding was used to
confirm the amyloid nature of fibrils formed by our PrP(106–126)
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Figure 1. Ultrastructural Characterization of
PrP(106–126) Fibrils
(A) TEM images of PrP(106–126) fibrils stained with
uranyl acetate, obtained at 60,0003 magnification.
The inset shows the details of an individual fibril,
viewed at 250,0003 magnification.
(B) An AFM image of PrP(106–126) fibrils, obtained
using tapping mode in air.
(C) Circular dichroism spectra of PrP(106–126)
dissolved in HFIP (dashed line), and of PrP(106–126)
fibrils suspended in pH 8.0 Tris buffer (solid line).
(D) Fluorescence emission spectra obtained for 20 mM
ThT in the presence or absence of PrP(106–126) fibrils
at the concentrations indicated.
peptides. Binding of this dye to polypeptide
chains is specific for the cross-b structure of
amyloid fibrils. As a function of the amount of
fibrils added to the solution, an increase in
ThT fluorescence at 480–490 nm is observed,
as shown in Figure 1D, supporting a cross-
b structure for PrP(106–126) fibrils.
13C and 15N Chemical Shifts Reveal
an Extended b Sheet, Spanning
Residues 113–123
Lyophilized PrP(106–126) fibrils, labeled with
13C and 15N as indicated in Table 1, were
studied using magic angle spinning (MAS) NMR. 1D 13C and
15N spectra of PrP(106–126)GAVL are shown in Figures 2A and
2B, respectively. 13C chemical shift assignments were made
directly from 1D spectra in cases where spectral overlap was
minimal or nonexistent (PrP[106–126]AAGG, PrP[106–126]ACO,
and PrP[106–126]GCO fibrils). Otherwise, assignments were
made by identifying the amino-acid specific spin systems in 2D
13C-13C chemical shift correlation spectra. An example of 13C
chemical shift assignment is shown in Figures 2C and 2D, with
the readily identified spin systems labeled in each case. 15N
chemical shifts were assigned using the N-Ca cross peaks in
15N-13C heteronuclear correlation spectra (not shown). The
same approach was used to assign all 13C and 15N resonances
in fibrils of PrP(106–126)AVG and PrP(106–126)AVG2 (see Figures
S1 and S2 available online). Chemical shifts for all labeled sites
are provided in Table S1.
13C secondary chemical shifts for all carbonyl, a, and
b carbons were calculated as the difference between the
observed chemical shifts and those reported for unstructured
peptides in solution (Wishart and Sykes, 1994). Due to the
dependence of backbone chemical shift values on local struc-
ture, these values can be used to define secondary structure
elements in proteins (Saito, 1986; Wishart and Sykes, 1994).
Results of this analysis are shown in Figure 3A, with residues
113–125 exhibiting upfield shifts of carbonyl and a carbons,
and downfield shifts of b carbons, characteristic of an extended
b-structure. G126 exhibits random coil chemical shift values,
with broad CO and Ca resonances indicative of significant struc-
tural heterogeneity. Backbone chemical shift data were used to
predict backbone f and c torsion angles for residues 114–125,418 Structure 17, 417–426, March 11, 2009 ª2009 Elsevier Ltd All rights reserved
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Structure of huPrP(106–126) Fibrilsusing TALOS (Cornilescu et al., 1999). These are listed in Table 2,
and support the presence of an extended b strand in the hydro-
phobic segment of PrP(106–126).
13C NMR line widths were measured for PrP(106–126) fibrils,
and are reported in Figure 3B. The line widths observed for the
majority of sites in the palindromic AGAAAAGA region of
PrP(106–126) fall into the range of 1.5–2.5 ppm, suggesting
a well-ordered protein structure (Petkova et al., 2002; Sharpe
et al., 2004), with the exception of the A113 side chain. Line
widths for V122 are also 2–2.5 ppm, whereas significantly
broader 13C lines were observed for residues V121, G123,
L125, and G126 (3.5–4.5 ppm for some sites), suggesting
reduced structural order or multiple conformations. Side-chain
atoms exhibiting significant line broadening relative to the back-
bone are likely exposed on the surface of the fibril, as opposed to
forming well-defined interactions in the core.
Upon hydration of PrP(106–126) fibrils, the 13C line widths for
A113 and G123 narrow by 0.5–1 ppm, whereas L125 and G126
lines are up to 2 ppm narrower (Figure S3). This suggests an
increase in local order upon hydration, such that all residues
exhibit line widths from 1.5–2.25 ppm, and is consistent with
an extended b-structure encompassing these residues. Overall,
our chemical shift and line width data are consistent with H/D
exchange rates reported for similar fibrils (Kuwata et al., 2003),
and support a model in which the hydrophobic residues 114–
124 form the core of PrP(106–126) fibrils.
One 13C-labeled site showed evidence of structural polymor-
phism, giving rise to two distinct resonances. In 10 ms radiofre-
quency assisted diffusion (RAD) spectra, two resonances are
observed for the methyl carbon of A118, at a 3:1 ratio. Lee
et al. (2008) have reported a 1:1 ratio of two methyl resonances
for all alanine residues in PrP(109–122) fibrils, likely due to the
front to back packing of sheets indicated by their data. In
PrP(106–126) fibrils, only A118 shows a doubling of the methyl
peak, and the 3:1 ratio does not support two equally populated
sites. At 250 and 500 ms RAD mixing, exchange is observed
between the two A118 methyl resonances, suggesting close
proximity of methyl groups with different packing interactions
in the same fibril. Because only this site gives rise to two distinct
peaks, it is unlikely that a second fibril morphology exists in our
PrP(106–126) fibrils.
Amyloid Fibrils of PrP(106–126) Are Composed
of In-Register Parallel b Sheets
The constant-time PITHIRDS experiment (Tycko, 2007) was
used to measure the average distance between a single 13C
Table 1. Amino Acid Sequence and Isotope Labeling Schemes for PrP(106–126) Peptides
Peptide Amino Acid Sequence
PrP(106–126)AVG KTNMKHMA113GAAAAGAV121VG123GLG
PrP(106–126)GAVL KTNMKHMAG114AA116AAGAVV122GGL125G
PrP(106–126)AAGG KTNMKHMAG(2-13C)A115A(1-13C)A117A(1-13C)G119AVVG(2-13C)G124LG
PrP(106–126)AVG2 KTNMKHMAGAAAA118GAV121VGGLG126
PrP(106–126)ACO KTNMKHMAGAAAAG(1-13C)A120VVGGLG
PrP(106–126)GCO KTNMKHMA(1-13C)G114AAAAGAVVGGLG
13C, 15N labeled amino acids were incorporated at the sites indicated in bold, with uniform isotope labeling, except for sites with selective incorporation
of 13C as indicated in parentheses.
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Figure 2. MAS NMR Spectra of PrP(106–126)GAVL
Fibrils
(A) 13C cross polarization spectrum of lyophilized fibrils,
obtained at an MAS spinning frequency of 10 kHz. Spinning
sidebands are indicated by asterisks.
(B) 15N cross polarization spectrum of the same sample, at an
MAS frequency of 10 kHz.
(C) 2D 13C-13C correlation spectrum obtained at 10 kHz MAS,
using a 10 ms RAD mixing period. In the direct dimension,
1024 complex points were acquired in the direct dimension,
with 200 increments at a dwell time of 25 ms acquired in
t1. A 10 kHz
1H field was applied during the RAD period and
64 scans were taken per FID.
(D) Expanded view of the 2D spectrum in (C), showing the
details of the aliphatic region. In (C) and (D), the resonance
assignments for each amino acid are shown.Structure 17, 417–426, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 419
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Structure of huPrP(106–126) Fibrilsatom on one PrP(106–126) peptide and the same site on adja-
cent peptides within the fibril. As a function of the recoupling
period, typically 0 to 60 ms, the magnetization will dephase at
a rate proportional to the 13C-13C dipolar coupling constant.
The dipolar coupling between two nuclei is in turn proportional
to 1/r3, where r is the internuclear distance. This has been shown
to be highly sensitive to interstrand packing with 4.8 A˚ distances
typically observed between backbone atoms in adjacent strands
of an in-register parallel b sheet.
The integrated 13C NMR peak intensities obtained as a function
of PITHIRDS recoupling time, for PrP(106–126)GCO, PrP(106–
126)ACO, the Ca of G124, and the Cb of A115 are shown in
Figure 4. These are plotted along with dephasing curves calcu-
lated using Spinevolution, and are best fit to 6.6, 6.2, 5.6 and
5.6 A˚ (±0.25 A˚) internuclear distances for samples labeled at
G114, A120, G124, and A115, respectively. For two of the three
sites, the observed distances are within the 5.5–6.0 A˚ range
observed for parallel b sheets in fibrils formed by b-amyloid
(Chimon et al., 2007; Petkova et al., 2005) and amylin (Luca
et al., 2007). The slower decay of 13C recoupling data relative
to that expected for an ideal b sheet has previously been attrib-
uted to the effects of transverse relaxation (Balbach et al., 2002),
and might also be symptomatic of minor structural heterogene-
ities within PrP(106–126) fibrils.
A
B
Figure 3. Secondary 13C Chemical Shifts and Line Widths Measured
for PrP(106–126) Fibrils
(A) The differences in 13C chemical shifts from the random coil values reported
by Wishart and Sykes (1994) are shown for each CO, Ca, and Cb resonance
assigned in this study, measured using 13C-13C 2D spectra obtained with
a RAD mixing period of 10 ms, or using 1D 13C spectra, where appropriate.
(B) 13C line widths for each assigned CO, Ca, and Cb resonance.
Table 2. Backbone f and c Torsion Angles Predicted for the
Sheet-Forming Region of PrP(106–126) Using TALOS Analysis
of 13C and 15N Chemical Shifts
Residue f () c ()
Gly114 143 (±16) 144 (±24)
Ala115 129 (±23) 144 (±14)
Ala116 140 (±14) 144 (±13)
Ala117 132 (±10) 150 (±14)
Ala118 127 (±11) 142 (±13)
Gly119 149 (±14) 159 (±14)
Ala120 110 (±27) 140 (±14)
Val121 137 (±15) 143 (±12)
Val122 128 (±11) 142 (±18)
Gly123 137 (±19) 148 (±23)
Gly124 97 (±27) 142 (±28)
Leu125 134 (±17) 140 (±18)
Figure 4. PITHIRDS Recoupling Curves for PrP(106–126) Fibrils
Dipolar dephasing curves obtained using the PITHIRDS homonuclear recou-
pling scheme are shown for the carbonyl 13C resonance in fibrils formed by
PrP(106–126)GCO (blue squares), PrP(106–126)ACO (green), the A115 Cb
resonance of PrP(106–126)AAGG fibrils (magenta), and the G124 Ca resonance
of PrP(106–126)AAGG fibrils (red). Simulated curves corresponding to inter-
atomic distances from 5.4 to 7.0 A˚ shown in 0.2 A˚ increments with the most
dephasing (lowest curve) being 5.4 A˚ and the least dephasing (highest curve)
at 7.0 A˚. Error bars for the PrP(106–126)GCO and A115 Cb data are smaller than
the points in the graph. Error bars were determined as the rms noise in the
spectra used for each data point.420 Structure 17, 417–426, March 11, 2009 ª2009 Elsevier Ltd All rights reserved
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Figure 5. Long-Range 13C-13C Internuclear Contacts Observed in 2D 13C-13C NMR Spectra of PrP(106–126)GAVL Fibrils
(A) 13C-13C correlation spectra obtained with a RAD mixing times of 10 ms. Similar spectra obtained with mixing times of 250 and 500 ms are shown in (B) and (C),
respectively. Horizontal slices at the G114Ca, A114Ca, and V122Ca frequencies are shown for 10 ms (D), 250 ms (E), and 500 ms (F) mixing times. Interresidue
cross peaks are indicated on the slices, and discussed in the text.These data provide strong evidence in favor of an in-register
parallel b sheet arrangement in PrP(106–126) fibrils. The longer
(6.6 A˚) interstrand distance observed at G114 might indicate
increased disorder of the sheet at the N terminus, in keeping
with decreased H/D exchange protection factors at this site.
This might be a result of repulsion between the positive charges
of K106 and K110. Despite the slightly longer distance between
G114 residues, the A120, G124, and A115 data rule out an anti-
parallel arrangement of strands within the PrP(106–126) fibrils. In
addition, the short distance measured between the A115 methyl
carbons strongly suggests the presence of an in-register b sheet,
because a shift in registry would significantly increase the sepa-
ration of A115 side chains in adjacent strands.
Quaternary Structure of PrP(106–126) Fibrils from 13C
Spin Diffusion and Rotational Resonance Experiments
13C-13C correlation spectra recorded using long (250–500 ms)
RAD spin diffusion periods allow cross peaks to be observed
between nuclei up to 6 A˚ apart (Petkova et al., 2006). Note that
transfer between nuclei with longer internuclear distances might
be observed due to sequential transfer during the spin diffusion
period. In Figure 5, a series of 13C spin diffusion spectra obtained
with 10, 250, and 500 ms RAD mixing are shown for PrP(106–
126)GAVL fibrils. As the mixing time is increased, cross peaks
resulting from long-range interresidue contacts between V122
and G114, as well as V122 and A116 (Figures 5D–5F), are
observed. Because of the distance between these residues in
an extended b strand, these peaks can only arise from proximity
of these residues in two closely packed sheets. At 250 ms all
G114 or A116 to V122 contacts are present with the exception
of A116Ca to V122Ca, which is only present at 500 ms mixing.
These data strongly suggest an arrangement of sheets within
the fibrils such that V122 is packed between G114 and A116.
This is supported by similar experiments carried out on
PrP(106–126)AVG fibrils (Figure S4), in which strong cross peaksStructure 17,between the side chain and backbone 13C atoms of A113 and
G123 are observed at both 250 and 500 ms RAD mixing. No
long-range contacts were observed at up to 500 ms RAD mixing
for either the AVG2 or AAGG samples.
To further characterize these intersheet packing interactions,
13C rotational resonance (RR) experiments were carried out on
the PrP(106–126)GAVL fibrils. The results of RR polarization trans-
fer between the carbonyl carbon of G114 and the Ca, Cb, and Cg
atoms of V122 are shown in Figure 6. When fit to simulated
curves, the distance between the G114CO and the Ca or Cb of
V122 were found to be approximately 4.5 and 5.0 A˚, respectively.
Although the two methyl resonances of V122 cannot be indepen-
dently resolved, the fit of the dephasing curve to 4.3–4.5 A˚
indicates close proximity of the G114CO to at least one of the
V122 methyl groups. Shorter distances observed between the
G114CO and V122Cb, relative to V122Ca, support an arrange-
ment in which the valine side chain is packed against the
backbone of A115, between the G114 and A116 side chains.
An alternate arrangement, in which the V122 side chain packs
against the amide group of G114 was ruled out based on
13C-15N fsREDOR (Gullion and Schaefer, 1989; Jaroniec et al.,
2001) and 2D 13C-15N TEDOR (Jaroniec et al., 2002) experiments
(data not shown) in which no polarization transfer between the
amide nitrogen of G114 and 13C nuclei in V122 was observed.
Based on signal to noise and limitations due to T2 relaxation
(Sharpe et al., 2004), our fsREDOR data suggest that this amide
group is at least 6 A˚ from any 13C atoms in V122.
Structural Model of PrP(106–126) Fibrils Based
on Solid-State NMR Measurements
An initial model for PrP(106–126) fibrils based on the intermolec-
ular contacts identified by solid state NMR is depicted in Figures
7A and 7B. Figure 7A shows the parallel arrangement of strands
dictated by the PITHIRDS experiments, whereas Figure 7B
shows the close intersheet packing consistent with 13C spin417–426, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 421
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and the absence of other close contacts in our fibril samples,
allow unambiguous alignment of PrP(106–126) in parallel
b sheets, which are stacked in an antiparallel manner to form
the fibril. f and c backbone torsion angles obtained from TALOS
were also included in the restraints used during energy minimiza-
tion and molecular dynamics (MD) simulations.
A representative minimized structure for a PrP(106–126) fibril
composed of ten peptide chains in each of two stacked b sheets
is shown in Figure 7C. The N-terminal residues from 106–112
show significant disorder, although the salt bridge formed
between K110 and the C-terminal carboxyl group of the opposing
strand restricts the movement of this segment. Residues 114–
123 form the tightly packed core of the fibril, and remain in an
in-register parallel b sheet after energy minimization. A slight twist
is evident in the minimized fibril structure, as expected for an
extended b-structure. In Figure 7D, the ensemble of structures
obtained for two strands in the middle of the fibril model are
shown, along with an average structure. Hydrophobic residues
forming the core of the fibril are tightly interdigitated with those
from the opposing sheet. At each end the M112 side chain is
accommodated by a slight deformation/bulge at G124/L125,
with L125 on the exterior of the fibril. Surface exposure of L125
is supported by the decrease in 13C line widths at this site upon
hydration of dry fibrils. The register of opposing sheets in this
model places the C terminus in a good position to form a salt
bridge with K110, as seen in the minimized structures.
DISCUSSION
The peptide comprising residues 106–126 of mammalian PrP
has been extensively studied as both a neurotoxic amyloid
Figure 6. Experimental 13C Rotational Resonance Data for
PrP(106–126)GAVL Fibrils and Simulated Polarization Transfer Curves
The differences in NMR peak areas (C1–C2) are plotted for each polarization
transfer experiment as a function of tRR, along with curves simulated using
r12 distances of 4, 4.5, 5, and 5.5 A˚ and T2
ZQ values of 1.2 ms (solid lines) or
1.0 and 1.4 ms (upper and lower dashed lines, respectively). The T2
ZQ values
obtained from single quantum T2 relaxation times for experimental C1, C2
spin pairs are 1.28 ± 0.17 ms (G114CO, V122Cg), 1.05 ± 0.17 ms (G114CO,
V122Cb), and 1.07 ± 0.15 ms (G114CO, V122Ca). Error bars were determined
as the rms noise in the spectra used for each data point.422 Structure 17, 417–426, March 11, 2009 ª2009 Elsevier Ltd All rigpeptide, and as a potential mediator of PrP conversion to the
scrapie form. In particular, the highly conserved palindromic
sequence AGAAAAGA has been implicated in the assembly of
amyloid fibrils and neurotoxicity of PrP(106–126) (Jobling et al.,
1999; Lee et al., 2008). In the present work, we have used
solid-state NMR to examine the molecular structure of amyloid
fibrils formed by PrP(106–126). Combined with TEM and AFM
measurements, we have produced an experimentally con-
strained structural model for the tightly packed core of these
fibrils. The overall morphology of our fibrils is consistent with
the observations of other groups (Forloni et al., 1993; Salmona
et al., 1999; Selvaggini et al., 1993).
After restrained energy minimization and molecular dynamics,
the structure obtained for the fibril core is consistent with the
formation of a class 1 steric zipper motif identified by Sawaya
et al. (2007), and closely resembles the quaternary packing
observed for fibrils of the b-amyloid protein (Petkova et al.,
2006). The extended hydrophobic segment spanning residues
G114 to G123 is involved in an extensive and tightly interdigi-
tated interface between the two parallel b sheets, including the
V122 to G114/A116 contacts observed in 13C spin diffusion
experiments. Two other factors that might stabilize the fibril
structure can be identified in the structural model. One is the
presence of a salt bridge between the C terminus and the
K110 side chain, which might explain the effects of C-terminal
amidation on PrP(106–126) fibril formation, as discussed below.
The second is the potential for the formation of an extended
chain ofp-p interactions between the side chains of H111, which
are closely aligned along the fibril long axis.
The structural model presented here provides a rational basis
for understanding the effects of sequence alterations on
PrP(106–126) assembly. For instance, altering the polarity of
the palindromic sequence by replacing the alanine residues
with serine dramatically reduces fibrillization, likely due to
reduced stability of the hydrophobic core (Jobling et al., 1999).
Likewise G114A/G119A double mutants form fibrils much less
readily (Florio et al., 2003). In our model, a G114A mutation would
add a methyl group to the pocket already occupied by V122 from
the opposing sheet, potentially inhibiting packing. A related
effect might account for observations that methionine oxidation
also reduces aggregation and alters the morphology of the
resulting fibrils (Bergstrom et al., 2007). Certainly increasing
the polarity of the tightly packed M112 side chain would desta-
bilize the hydrophobic interface in our fibrils. The A117V mutation
observed in some GSS patients actually enhances fibril forma-
tion, which is consistent with its location on the exterior of our
fibrils, rather than in the core. Similarly, it has been observed
that PrP(106–126) forms fibrils more readily at pH 7 than at pH
5, an effect most readily explained by a change in the protonation
state of H111 (Salmona et al., 1999). Because of the close prox-
imity of H111 side chains in our fibrils, a positive charge in this
position would likely have a strong destabilizing effect.
It is important to note that in several of the cases mentioned
above, there is not only a reduced fibril formation but an
apparent change in fibril morphology. It is evident from exam-
ining the sequence of PrP(106–126) that the extended hydro-
phobic interface can accommodate more than one favorable
mode of packing. Thus, subtle mutations might promote the
formation of non-wild-type interactions. A similar phenomenonhts reserved
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Figure 7. Structural Models of PrP(106–126) Fibrils
(A) Schematic of a single parallel sheet formed by PrP(106–126), with residues G114, A120, and G124 shown in blue, green, and red, respectively.
(B) Ball-and-stick model showing the key intersheet packing interactions consistent with 13C spin diffusion and RR NMR experiments.
(C) A typical structural model obtained after energy minimization and restrained molecular dynamics of PrP(106–126) fibrils. The two parallel b sheets are shown in
orange and blue, with the disordered N and C termini shown in gray.
(D) Cross section of the fibril shown in (C), highlighting the packing interactions between two peptides in opposing b sheets. The upper panel shows 12 overlaid
structures for each strand, as obtained from multiple rounds of MD and minimization. The lower panel shows a single average structure (calculated by MOLMOL),
with selected residues from the lower strand labeled as a guide. Amino acids are color coded by type, with green, blue, red, and magenta indicating hydrophobic,
positively charged, negatively charged (here the C-terminal glycine), and polar side chains, respectively.might account for the different structural models derived for
fibrils formed by three closely related PrP peptide sequences.
In particular, the molecular dynamics simulations performed
by Kuwata et al. (2003) were performed using an amidated
form of the mouse PrP(106–126), corresponding to human PrP
residues 107–127, and containing valine residues in place of
M109 and M112. Although our structure is consistent with their
reported H/D exchange data, their simulations suggested
a parallel stacking of parallel b sheets to be the energetically
preferred structure. It is likely that amidation of the C terminus,
which removes the charge pairing with K110 in our model, would
significantly alter peptide packing. By contrast, our model
matches a previous proposal in the presence of a salt bridge at
this position was suggested (Salmona et al., 1999). In fact, it
has been noted by several groups that amidation of PrP(106–
126) inhibits fibril formation, and significantly alters the mecha-
nism of peptide toxicity in vivo (Bergstrom et al., 2007; Salmona
et al., 1999).
Recent solid-state NMR and FTIR studies of fibrils formed by
an amidated and acetylated PrP(109–122) peptide have pre-
sented strong evidence for a class 6, 7, or 8 steric zipper, in
which antiparallel b sheets stack in a face-to-back manner to
form the fibril (Lee et al., 2008; Silva et al., 2003). This peptide
is significantly different from the uncapped 106–126 sequence
in our work, and is likely to exhibit different packing arrangement
in amyloid fibrils. As noted above, amidation and other modifica-
tions appear to dramatically alter the physical and biological
properties of this peptide, such that understanding the factors
driving the formation of these different structures will be of signif-Structure 17,icant value. Similar switches between parallel and antiparallel
b sheets have been observed in peptides based on the Alzheimer
b-amyloid protein, and appear to stem from changes in align-
ment of polar residues and different hydrophobic packing in
peptides of slightly differing length and/or sequence (Tycko,
2006).
It has been suggested that PrP(106–126) fibrils might have
direct relevance to prion biology. In most cases, toxicity of
PrP(106–126) requires expression of PrP in the target cells (Thel-
lung et al., 2000; Pietri et al., 2006; Forloni et al., 1993; Gong
et al., 2007; Ettaiche et al. 2000). Brown (2000) has suggested
a direct interaction with PrPC, whereas Gu et al. (2002) demon-
strated that PrP(106–126) can catalyze formation of protease-
resistant PrP in neuroblastoma cells. Along similar lines, deletion
of G114-A120 is protective against PrPSc (Holscher et al., 1998).
It is tempting, therefore, to suggest that the structures of aggre-
gated forms of this peptide, such as the fibril model presented
here, might share common elements with PrPSc, or might reveal
insight into the mechanism of PrP conversion. This concept finds
strong support in a recent study in which antibodies against
aggregated, nonamidated PrP(106–126) are able to selectively
bind to PrPSc versus PrPC (Jones et al., 2008).
In conclusion, we have produced the first experimentally
constrained structural model for amyloid fibrils formed by
PrP(106–126). Our data support the presence of a class 1 steric
zipper in the hydrophobic core of these fibrils, giving rise to
favorable van der Waals interactions within the sheet-sheet inter-
face that are supplemented by the presence of a salt bridge
between the C terminus and the side chain of Lys110. Our model417–426, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 423
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this sequence on peptide aggregation, and accounts for the
reported inability of PrP(106–126) peptides with amidated
C termini to form fibrils. Although the putative roles of PrP(106–
126) in toxicity and in PrP conversion remain undefined,
increased knowledge regarding the aggregated states of this
peptide represents an important step toward understanding
these processes.
EXPERIMENTAL PROCEDURES
PrP(106–126) Fibril Formation
PrP(106–126) peptides were prepared by solid phase peptide synthesis, using
standard 9-fluorenylmethoxycarbonyl chemistry (APTC, Hospital for Sick Chil-
dren). For NMR experiments, six selective labeling schemes were devised,
with incorporation of 13C and 15N amino acids (Spectra Stable Isotopes and
Cambridge Isotope Laboratories) at the sites indicated in Table 1. The final
product was purified by reverse-phase high performance liquid chromatog-
raphy, using an 11 3 300mm C8 peptide column (Vydac) and a gradient of
0 to 54% acetonitrile (ACN) with 0.1% TFA. PrP(106–126) eluted at 32%
ACN (confirmed by mass spectrometry) and was freeze-dried.
To form fibrils, 25 mg peptide was dissolved in 1 ml HFIP (Fluka), vortexed
and sonicated for 5min, then allowed to stand at room temperature for
10 min. HFIP was evaporated under a stream of N2 (g), and the resulting peptide
film was resuspended in 5 ml 20 mM Tris buffer (pH 8.0), vortexed to mix, and
briefly sonicated. In order to promote complete and rapid fibril formation, the
reaction was self-seeded. For seeding, 100 ml of the initial fibril solution was
removed, briefly probe sonicated, and returned. Fibrillization reactions were al-
lowed to stand at room temperature until a noticeable change in viscosity was
achieved, as indicated by the formation of a gel-like suspension, usually occur-
ring after 5–7 days. Samples to be analyzed by solid state NMR were dialysed
against 4 l Millipore water overnight with a 3500 Da cutoff membrane (Spectra-
pore), to remove residual peptide monomers, and subsequently lyophilized.
Circular Dichroism Spectroscopy
The secondary structure of PrP(106–126) was analyzed by CD using a Jasco
J-810 spectropolarimeter and a quartz cuvette with a 1.0 mm path length.
The CD spectrum of monomeric peptide was obtained using 0.5 mg/ml
peptide in HFIP. Fibrillar samples were briefly probe sonicated before
measurement to reduce light scattering. Reported spectra are the sum of three
wavelength scans from 190–250 nm, recorded at 100 nm/min.
Thioflavin-T Fluorescence
Binding of ThT to PrP(106–126) fibrils was assayed by adding freshly prepared
20 mM ThT (Sigma) to a solution of 3, 30, or 60 mM fibrils. Fluorescence was
monitored using a Photon Technology International C60 spectrofluorimeter
with excitation and emission slit widths set to 2 and 5 nm, respectively. Spectra
were obtained by scanning the fluorescence emission from 430 to 600 nm,
with excitation at 442 nm. Experimental spectra were compared with a control
spectrum obtained using a solution of 20 mM ThT in fibrillization buffer (20 mM
Tris [pH 8.0]).
Transmission Electron Microscopy
Samples for electron microscopy were deposited on fresh continuous carbon
films prepared from copper rhodium grids (Electron Microscopy Sciences).
Before adding samples, the grids were charged using a glow discharger for
15 s at 30 mA negative discharge. Fibril solutions of 0.5 mg/ml were adsorbed
to grids for 2 min before rinsing with 10 ml water for 10 s. Samples were blotted
using No. 2 Whatman filter paper and stained with freshly filtered 2% uranyl
acetate for 15 s. TEM images were obtained using a Jeol 1011 microscope
operating at 80 kV.
Atomic Force Microscopy
A 0.5 mg/ml solution of fibrils was adsorbed to a freshly cleaved mica surface
on a solid support, blotted to remove excess material, and air-dried. Fibrils
were analyzed using a Nanoscope IIIa Multimode scanning probe microscope424 Structure 17, 417–426, March 11, 2009 ª2009 Elsevier Ltd All r(Digital Instruments/Veeco) operating in tapping mode to acquire images with
an area of 1, 2, and 5 mm2. Height profiles along the length of individual fibrils
were obtained, as well as a series of profiles taken perpendicular to the fibril
long axis. An average height for PrP(106–126) fibrils was calculated from this
data, with error reported as standard deviation from the mean.
Solid-State NMR
Lyophilized fibrils were packed into standard 22 ml 3.2 mm MAS rotors. For
experiments on hydrated fibrils, an equal mass of water was added to the
dry sample in the rotor, followed by centrifugation and incubation for at least
1 hr to ensure uniform incorporation of water. Solid state NMR measurements
were carried out on a narrow bore Varian VNMRS spectrometer, operating at
a 1H frequency of 499.82 MHz. All experiments were carried out using Varian
triple-resonance 3.2 mm T3 MAS and BioMAS probes. Sample heating in
standard T3 probes was alleviated by delivering high-flow rates of ambient
temperature dry air to the sample. All spectra were externally referenced to
the downfield 13C resonance of adamantane at 38.56 ppm relative to tetrame-
thylsilane (Morcombe and Zilm, 2003).
13C and 15N cross polarization was implemented using a linear ramped ra-
dio frequency (rf) field centered around 40–60 kHz on the low channel, with
a 50–80 kHz field on the 1H channel and contact times of 1–1.5 ms. p/2 pulse
widths were typically 2.2–3 ms for all channels on the T3 MAS probe, or 2.5 ms
(1H) and 5.5 ms (13C, 15N) on the BioMAS probe. 1H decoupling fields of 110 kHz
were applied during all t1 and t2 periods, using the TPPM decoupling scheme
(Bennett et al., 1995). In all cases, a 2 s delay was used between scans.
Two-dimensional 13C-13C NMR spectra were obtained using a RAD recou-
pling sequence (Morcombe et al., 2004; Takegoshi et al., 2001). RAD mixing
times of 10, 250, and 500 ms were used, at an MAS frequency of 10 kHz. 2D
15N-13C correlation spectra were obtained using a double cross polarization
pulse sequence in which 15N to 13C cross polarization after the t1 period was
achieved with radiofrequency fields of 40 to 60 kHz on each channel and
a linear ramp on the 15N channel with a contact time of 1.5 ms. Two hundered
points were taken in t1 with a dwell of 25 ms and a total of 512 scans per free
induction decay (FID).
Constant time 13C recoupling experiments were performed using the
PITHIRDS pulse sequence as described by Tycko (2007), with k1 equal to
4 and k2 and k3 decremented and incremented from 23 to 0 and 0 to 23,
respectively, giving 50.4 ms total dipolar recoupling. PITHIRDS spectra were
obtained at a MAS rate of 20 kHz, such that 16.67 msppulses were used during
the recoupling period. Each spectrum was taken at a sweep width of 20161 Hz
with 1600 scans per FID. The PITHIRDS pulse sequence was tested using
carboxylate-labeled L-alanine, with results similar to Tycko (2007).
Rotational resonance experiments (Raleigh et al., 1988) were performed at
the n = 1 RR condition, using a 1–4 ms Gaussian p pulse for selective inversion
of the C1 peak. For each RR time point (tRR) in the experimental S1 curves,
a reference signal (S0) was also recorded, without inversion of the C1 signal.
After obtaining a difference spectrum (S0 S1) for each time point, polarization
transfer was calculated as the difference in peak areas (C1 – C2), normalized to
the C1 peak area at tRR = 0. For accurate fits of RR polarization transfer curves,
13C zero-quantum coherence relaxation time (T2
ZQ) values for each spin pair
C1 and C2 were estimated from single-quantum T2 values using the equation
(T2
ZQ)1 = (T2
C1)1 + (T2
C2)1. Spin echo spectra for T2 measurements were re-
corded under similar conditions of 1H decoupling and MAS rate to the RR
experiments.
NMR Data Analysis
All 2D spectra were processed in NMRPipe and visualized using NMRDraw
(Delaglio et al., 1995), whereas 1D spectra were processed using VNMRJ
(Varian Inc.). The number of points used for Fourier transformation in each
dimension was doubled by zero filling, and an exponential line broadening
function of 50–150 Hz was typically applied to each FID. TALOS (Cornilescu
et al., 1999) was used to obtain predicted c and f backbone torsion
angles for PrP(106–126) in amyloid fibrils, based on 13C and 15N chemical shift
data.
Simulations of NMR data were carried out using Spinevolution (Veshtort and
Griffin, 2006). PITHIRDS dephasing curves were calculated using a linear
arrangement of five equidistant 13C atoms and an explicit treatment of the
pulse sequence, observing only the central spin. Before fitting, the naturalights reserved
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This was calculated as 16.5% of the initial peak area for A120 (due to overlap-
ping contributions of 15 natural abundance carbonyl shifts), 4.4% of the initial
peak area for G114 and G124 (4 additional glycine residues), and 11% for A115
(overlap from alanine and valine methyl carbons). Root mean square (rms)
noise was calculated from baseline regions of each spectrum, using integral
widths identical to those for the peak of interest, and was normalized against
the area of the first peak. Experimental PITHIRDS data were fit to simulations
using the weighted sum of squared residuals S2:
S2 =
X
y  by2,w;
where y is the value of the experimental data point (normalized intensity), by is
the corresponding simulated data point (normalized intensity), and w is
a weighting factor; in this case, w corresponds to the span of the rms noise.
The RR polarization transfer was simulated using four spins chosen to repre-
sent the C1 and C2 nuclei and one directly bonded 13C spin for each nucleus.
There is a negligible dependence of the RR transfer on CSA values and relative
tensor orientations under our sample conditions (finite T2
ZQ values and internu-
clear distances greater than 2.5 A˚), such that only the C1 – C2 distance (r12) and
T2
ZQ values are required for fitting. Both variables were explicitly included in
the Spinevolution calculations.
PrP Fibril Modeling
An initial model of PrP(106–126) fibrils was built in MOLMOL (Koradi et al.,
1996) as an ideal parallel in-register b sheet composed of ten strands. Two
sheets were stacked in an antiparallel arrangement using close intersheet
contacts consistent with 13C RAD and RR data. Multiple rounds of restrained
energy minimization and MD were carried out using Tinker/Forcefield explorer
(available at http://dasher.wustl.edu/tinker/), resulting in an ensemble of ten
structures. The CHARMM27 forcefield was used for all calculations. Structural
constraints on internuclear distances and backbone torsion angles made use
of harmonic potential energy functions to restrain models as described below.
An initial round of energy minimization was performed with torsion angles from
residues 115–123 of f = 120 and c = 113, representing an ideal parallel
b sheet conformation. Subsequently, torsion angles were restrained to the
values obtained from TALOS for a second round of energy minimization and
for restrained molecular dynamics. Hydrogen bonding between strands was
enforced as 2.15 A˚ distances between backbone carbonyl oxygens and amide
hydrogens from residues 115–123. Intersheet contacts obtained from 13C spin
diffusion experiments were defined as < 8 A˚ distances between pairs of atoms
in G114/V122, A116/V122, and A113/G123. The stability of the final model ob-
tained was confirmed using unrestrained molecular dynamics simulations. Key
interstrand contacts were preserved for longer than 100 ps at temperatures of
up to 400 K, and the fibril structure remained intact. Some global distortions
were observed at higher temperatures, likely due to the artificially short fibril
being simulated.
SUPPLEMENTAL DATA
Supplemental Data include four figures and one table and can be found
with this article online at http://www.cell.com/structure/supplemental/
S0969-2126(09)00064-1.
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